Wolverine Trading, LLC Compugen LTD Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $64,536 - $112,977	-15,779 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $30,548 - $42,241	-5,267 Reduced 25.03%	15,779 $93,000
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $80,818 - $145,094	10,537 Added 100.27%	21,046 $172,000
Q4 2020 Feb 12, 2021	SELL	$12.07 - $17.95 $126,372 - $187,936	-10,470 Reduced 49.91%	10,509 $136,000
Q2 2020 Aug 13, 2020	BUY	$6.97 - $17.12 $70,397 - $172,912	10,100 Added 92.84%	20,979 $295,000
Q2 2019 Aug 20, 2019	BUY	$2.8 - $4.14 $554 - $819	198 Added 1.85%	10,879 $42,000
Q1 2019 May 15, 2019	SELL	$2.35 - $4.19 $9,190 - $16,387	-3,911 Reduced 26.8%	10,681 $44,000
Q3 2018 Nov 14, 2018	SELL	$3.0 - $4.05 $12,723 - $17,176	-4,241 Reduced 22.52%	14,592 $56,000
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $47,082 - $83,806	18,833 New	18,833 $84,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.